CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 401 filers reported holding CRISPR THERAPEUTICS AG in Q4 2022. The put-call ratio across all filers is 0.90 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $6,265 | -20.8% | 116 | 0.0% | 0.00% | -33.3% |
| Q1 2024 | $7,907 | +8.9% | 116 | 0.0% | 0.00% | 0.0% |
| Q4 2023 | $7,262 | -80.9% | 116 | -86.1% | 0.00% | -82.4% |
| Q3 2023 | $37,946 | +3954.1% | 836 | -95.0% | 0.02% | -95.9% |
| Q2 2023 | $936 | +19.8% | 16,668 | -3.5% | 0.42% | +10.9% |
| Q1 2023 | $781 | +10.2% | 17,268 | -1.0% | 0.38% | +2.5% |
| Q4 2022 | $709 | -99.9% | 17,448 | -7.5% | 0.37% | -42.6% |
| Q3 2022 | $1,232,000 | +5.9% | 18,853 | -1.5% | 0.64% | +11.5% |
| Q2 2022 | $1,163,000 | -3.3% | 19,140 | -0.1% | 0.57% | +17.9% |
| Q1 2022 | $1,203,000 | -16.7% | 19,160 | +0.5% | 0.48% | -10.0% |
| Q4 2021 | $1,444,000 | -27.4% | 19,060 | +7.3% | 0.54% | -35.8% |
| Q3 2021 | $1,989,000 | -2.9% | 17,766 | +1.3% | 0.84% | -0.2% |
| Q2 2021 | $2,049,000 | +1.9% | 17,541 | +6.3% | 0.84% | -13.7% |
| Q1 2021 | $2,010,000 | -17.8% | 16,498 | +3.4% | 0.97% | -22.2% |
| Q4 2020 | $2,444,000 | +24.4% | 15,962 | -1.2% | 1.25% | +20.5% |
| Q3 2020 | $1,964,000 | +61.2% | 16,157 | -2.5% | 1.04% | +37.6% |
| Q2 2020 | $1,218,000 | +47.6% | 16,567 | -1.2% | 0.76% | +35.5% |
| Q1 2020 | $825,000 | +27400.0% | 16,772 | +33444.0% | 0.56% | +27750.0% |
| Q4 2019 | $3,000 | +50.0% | 50 | 0.0% | 0.00% | +100.0% |
| Q3 2019 | $2,000 | 0.0% | 50 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $2,000 | 0.0% | 50 | 0.0% | 0.00% | -50.0% |
| Q1 2019 | $2,000 | – | 50 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $37,781,000 | 20.21% |
| Ariose Capital Management Ltd | 37,900 | $2,872,000 | 6.78% |
| EcoR1 Capital, LLC | 1,077,483 | $81,652,000 | 2.60% |
| NEA Management Company, LLC | 1,590,002 | $120,490,000 | 2.44% |
| ARK Investment Management | 9,087,868 | $688,679,000 | 2.08% |
| NIA IMPACT ADVISORS, LLC | 62,609 | $3,876,000 | 2.06% |
| Deuterium Capital Management, LLC | 18,000 | $1,364,000 | 2.02% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 108,200 | $8,192,000 | 1.82% |
| PLUSTICK MANAGEMENT LLC | 50,000 | $3,789,000 | 1.76% |
| Nikko Asset Management Americas, Inc. | 4,319,471 | $330,526,000 | 1.74% |